Quick member survey – improving PV communication

Communications / 14 April 2022

If you have a spare couple of minutes, your input can help UMC continue to improve our pharmacovigilance communication methods.


As some of Uppsala Reports’ readers may have already seen, UMC recently created an animated explainer video to raise awareness of vigiGroup – UMC’s cluster analysis method developed to identify groups of ADR reports with similar adverse events. The purpose of the video, which was shared widely on social media, was to offer an alternative way to communicate the methodology put forward in UMC’s academic paper “Consensus clustering for case series identification and adverse event profiles in pharmacovigilance.”

At UMC, we are always looking to develop, evolve, and refine how we communicate the science of pharmacovigilance, and this project provides us with an excellent opportunity to do just that. We would like to assess the effectiveness of animated explainer videos to convey complex scientific methods by getting feedback from you, our readers, in the form of a short survey. It will only take a few minutes of your time and you don’t need a PV or scientific background to take part.

The survey, along with the explainer video, is available here:

Take the survey

 

Thanks for you help.

Matthew Barwick
Communications officer & video producer, UMC

You may also like


Winning the war against health mis and disinformation

Public health is at risk now more than ever; with AI it has never been easier to spread mis- and disinformation on health. How do we work smarter to address this threat?

17 June 2025

Ronald Meyboom: A professional life devoted to pharmacovigilance

Ronald Meyboom, pioneering pharmacovigilance expert who helped establish drug safety monitoring in the Netherlands, died 27 April. He was 79.

11 June 2025

Pharmacovigilance: Back to the Future with ISoP 2025

The theme of this year’s conference is inspired by Cairo’s rich cultural and scientific history and commitment to advancing drug safety and regulatory science.

19 March 2025